← FDA Drug Approvals (Drugs@FDA)

ZELSUVMI

NDA · New Drug Application · Sponsor: LNHC · Approved 2024-01-05

Drug application

FDA Application #

NDA217424

Application type

New Drug Application

Brand name

ZELSUVMI

Generic name

BERDAZIMER

Active ingredients

BERDAZIMER SODIUM

Dosage form

GEL

Route

TOPICAL

Marketing status

Prescription

Sponsor

LNHC

Manufacturer

LNHC, Inc.

First approval

2024-01-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown